Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ticlopidine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : Yuyu Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Clopidogrel Resistance and Embolism in Carotid Artery Stenting
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 08, 2014
Lead Product(s) : Ticlopidine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : Yuyu Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable